About Luminex Corporation
Luminex Corporation is a company based in Austin (United States) founded in 1995 was acquired by DiaSorin in April 2021. The company has 1,004 employees as of December 31, 2022. Luminex Corporation has completed 4 acquisitions, including EraGen Biosciences, Genturadx and Nanosphere. Luminex Corporation offers products and services including LIAISON XL, xMAP Technology, and MAGPIX System. Luminex Corporation operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Aldevron, Blaze Bioscience and Teknova, among others.
- Headquarter Austin, United States
- Employees 1004 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$417.4 M (USD)25as on Dec 31, 2020
-
Net Profit
$15.17 M (USD)495as on Dec 31, 2020
-
EBITDA
$42.44 M (USD)451as on Dec 31, 2020
-
Latest Funding Round
$11.3 M (USD), Grant
Feb 19, 2021
-
Investors
DiaSorin
& 3 more
-
Employee Count
1004
as on Dec 31, 2022
-
Investments & Acquisitions
EraGen Biosciences
& 3 more
-
Acquired by
DiaSorin
(Apr 12, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Luminex Corporation
Luminex Corporation offers a comprehensive portfolio of products and services, including LIAISON XL, xMAP Technology, and MAGPIX System.
Automated system for immunodiagnostic testing of diseases.
Platform for simultaneous biomarker detection in research.
Device for multiplex assays in diagnostics and life sciences.
People of Luminex Corporation
Unlock access to complete
Unlock access to complete
Leadership Team
21 people
Sales and Marketing
18 people
Software Development Team
11 people
Finance and Accounting
10 people
Human Resources and Administration
8 people
Corporate Team
4 people
Senior Team
4 people
Product Management Team
4 people
Unlock access to complete
Funding Insights of Luminex Corporation
Investors in Luminex Corporation
Luminex Corporation has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include DiaSorin, Public Health Emergency and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Luminex Corporation
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Luminex Corporation
Luminex Corporation has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include EraGen Biosciences, Genturadx and Nanosphere.
Investment portfolio details for Luminex Corporation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Molecular diagnostic platforms for clinical PCR analysis are developed.
|
Locked | Locked | 2005 | Locked | |
|
Diagnostic tests for personalized medicine targeting infections are provided.
|
Locked | Locked | 1999 | Locked | |
|
Molecular reagents and diagnostic assays for disease detection are developed.
|
Locked | Locked | 1994 | Locked |
Complete acquisition details for Luminex Corporation
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Luminex Corporation
Detailed financials for Luminex Corporation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Luminex Corporation Comparisons
Peer comparison for Luminex Corporation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Luminex Corporation
Luminex Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Aldevron, Blaze Bioscience and Teknova, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Blaze Bioscience is focused on improving cancer patient outcomes.
|
|
| Locked | Locked | Locked |
Molecular biology reagents and kits are supplied for research applications.
|
|
| Locked | Locked | Locked |
Molecular diagnostic device and kits
|
Detailed competitors of Luminex Corporation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Luminex Corporation
Complete news archive for Luminex Corporation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Luminex Corporation
Luminex Corporation was founded in 1995 and raised its 1st funding round 13 years after it was founded.
Luminex Corporation is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
As of Dec 31, 2022, the latest employee count at Luminex Corporation is 1,004.
Annual revenue of Luminex Corporation is $417.4M as on Dec 31, 2020.
Luminex was founded in 1995 in Austin, United States, and operates within the biotechnology sector. Instruments, reagents, and kits are developed for clinical diagnostics and life science research applications. Bead- and tag-based technologies are specialized in for multiplexing immunoassays and nucleic acid assays. Clinical diagnostic solutions are provided for infectious diseases and genetic disorders, supporting operations across research and healthcare domains.
Luminex Corporation's top competitors include Abcam, Meridian Bioscience and Aldevron.
Luminex Corporation offers LIAISON XL, xMAP Technology, and MAGPIX System.
Luminex Corporation has made 4 acquisitions, including EraGen Biosciences, Genturadx, and Nanosphere.
Luminex Corporation has 4 investors. Key investors include DiaSorin, Public Health Emergency, National Science Foundation, and HHS.